Posted by Michael Wonder on 20 Feb 2023
EMA publishes agenda for 20-23 February 2023 CHMP meeting
20 February 2023 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue opinions for the following technologies:
- Abiraterone acetate and niraparib tosylate monohydrate
- Eculizumab
- Pegunigalsidase alfa
- Sirolimus
- Ivosidenib
- Vadadustat
